Supernus Pharmaceuticals

forest woods paths paths diverge
Biotech

Supernus depression drug candidate fails midstage trial

Patients given SPN-820 showed no improvement in their Montgomery-Åsberg Depression Rating Scale scores, a measure of symptom severity.
Darren Incorvaia Feb 19, 2025 6:40am
Man on chair with head in hand

Supernus links depression drug to fast responses in ph. 2 trial

Oct 18, 2024 9:17am